LICHEN INTERNATIONAL LTD (LICN) Fundamental Analysis & Valuation

NASDAQ:LICNKYG5479G1165

Current stock price

6.5 USD
+0.35 (+5.69%)
Last:

This LICN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. LICN Profitability Analysis

1.1 Basic Checks

  • In the past year LICN has reported negative net income.
  • LICN had a negative operating cash flow in the past year.
  • Of the past 5 years LICN 4 years were profitable.
  • LICN had a positive operating cash flow in 4 of the past 5 years.
LICN Yearly Net Income VS EBIT VS OCF VS FCFLICN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

  • LICN's Return On Assets of -24.20% is on the low side compared to the rest of the industry. LICN is outperformed by 82.56% of its industry peers.
  • Looking at the Return On Equity, with a value of -25.31%, LICN is doing worse than 72.09% of the companies in the same industry.
Industry RankSector Rank
ROA -24.2%
ROE -25.31%
ROIC N/A
ROA(3y)7.28%
ROA(5y)12.15%
ROE(3y)8.07%
ROE(5y)14.07%
ROIC(3y)N/A
ROIC(5y)N/A
LICN Yearly ROA, ROE, ROICLICN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • LICN has a better Gross Margin (56.60%) than 75.58% of its industry peers.
  • In the last couple of years the Gross Margin of LICN has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for LICN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.21%
GM growth 5YN/A
LICN Yearly Profit, Operating, Gross MarginsLICN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

9

2. LICN Health Analysis

2.1 Basic Checks

  • LICN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, LICN has less shares outstanding
  • LICN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LICN Yearly Shares OutstandingLICN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
LICN Yearly Total Debt VS Total AssetsLICN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • LICN has an Altman-Z score of 21.55. This indicates that LICN is financially healthy and has little risk of bankruptcy at the moment.
  • LICN has a Altman-Z score of 21.55. This is amongst the best in the industry. LICN outperforms 96.51% of its industry peers.
  • There is no outstanding debt for LICN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.55
ROIC/WACCN/A
WACC7.54%
LICN Yearly LT Debt VS Equity VS FCFLICN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • LICN has a Current Ratio of 10.19. This indicates that LICN is financially healthy and has no problem in meeting its short term obligations.
  • LICN has a better Current ratio (10.19) than 97.67% of its industry peers.
  • A Quick Ratio of 10.19 indicates that LICN has no problem at all paying its short term obligations.
  • LICN has a Quick ratio of 10.19. This is amongst the best in the industry. LICN outperforms 97.67% of its industry peers.
Industry RankSector Rank
Current Ratio 10.19
Quick Ratio 10.19
LICN Yearly Current Assets VS Current LiabilitesLICN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

1

3. LICN Growth Analysis

3.1 Past

  • LICN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -215.99%.
  • The Revenue for LICN has decreased by -10.23% in the past year. This is quite bad
  • The Revenue has been growing slightly by 6.54% on average over the past years.
EPS 1Y (TTM)-215.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-741.19%
Revenue 1Y (TTM)-10.23%
Revenue growth 3Y6.54%
Revenue growth 5YN/A
Sales Q2Q%-21.2%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LICN Yearly Revenue VS EstimatesLICN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M

0

4. LICN Valuation Analysis

4.1 Price/Earnings Ratio

  • LICN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LICN Price Earnings VS Forward Price EarningsLICN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LICN Per share dataLICN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. LICN Dividend Analysis

5.1 Amount

  • No dividends for LICN!.
Industry RankSector Rank
Dividend Yield 0%

LICN Fundamentals: All Metrics, Ratios and Statistics

LICHEN INTERNATIONAL LTD

NASDAQ:LICN (4/21/2026, 8:00:03 PM)

6.5

+0.35 (+5.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap106.14M
Revenue(TTM)37.64M
Net Income(TTM)-16.26M
AnalystsN/A
Price TargetN/A
Short Float %0.23%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.82
P/FCF N/A
P/OCF N/A
P/B 1.65
P/tB 2.11
EV/EBITDA N/A
EPS(TTM)-67.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.67
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS2.31
BVpS3.93
TBVpS3.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -24.2%
ROE -25.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.6%
FCFM N/A
ROA(3y)7.28%
ROA(5y)12.15%
ROE(3y)8.07%
ROE(5y)14.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.21%
GM growth 5YN/A
F-Score2
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 546%
Cap/Sales 42.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.19
Quick Ratio 10.19
Altman-Z 21.55
F-Score2
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)216.31%
Cap/Depr(5y)140.76%
Cap/Sales(3y)15.05%
Cap/Sales(5y)9.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-741.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.23%
Revenue growth 3Y6.54%
Revenue growth 5YN/A
Sales Q2Q%-21.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-203.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1090.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-303.31%
OCF growth 3YN/A
OCF growth 5YN/A

LICHEN INTERNATIONAL LTD / LICN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LICHEN INTERNATIONAL LTD?

ChartMill assigns a fundamental rating of 3 / 10 to LICN.


What is the valuation status of LICHEN INTERNATIONAL LTD (LICN) stock?

ChartMill assigns a valuation rating of 0 / 10 to LICHEN INTERNATIONAL LTD (LICN). This can be considered as Overvalued.


Can you provide the profitability details for LICHEN INTERNATIONAL LTD?

LICHEN INTERNATIONAL LTD (LICN) has a profitability rating of 2 / 10.


How financially healthy is LICHEN INTERNATIONAL LTD?

The financial health rating of LICHEN INTERNATIONAL LTD (LICN) is 9 / 10.